BIOMAT Database Logo BIOMAT Database Logo

[Long-term use of indirect anticoagulants in patients with obliterating atherosclerosis of peripheral arteries]. 1985

Kh Khaĭne, and K Norden, and Kh Makh, and Kh Shmidt

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D002544 Cerebral Infarction The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction). Anterior Choroidal Artery Infarction,Cerebral Infarct,Infarction, Cerebral,Posterior Choroidal Artery Infarction,Subcortical Infarction,Cerebral Infarction, Left Hemisphere,Cerebral Infarction, Right Hemisphere,Cerebral, Left Hemisphere, Infarction,Cerebral, Right Hemisphere, Infarction,Infarction, Cerebral, Left Hemisphere,Infarction, Cerebral, Right Hemisphere,Infarction, Left Hemisphere, Cerebral,Infarction, Right Hemisphere, Cerebral,Left Hemisphere, Cerebral Infarction,Left Hemisphere, Infarction, Cerebral,Right Hemisphere, Cerebral Infarction,Right Hemisphere, Infarction, Cerebral,Cerebral Infarctions,Cerebral Infarcts,Infarct, Cerebral,Infarction, Subcortical,Infarctions, Cerebral,Infarctions, Subcortical,Infarcts, Cerebral,Subcortical Infarctions
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D001162 Arteriosclerosis Obliterans Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION. Obliterans, Arteriosclerosis
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

Kh Khaĭne, and K Norden, and Kh Makh, and Kh Shmidt
[Long-term results of conservative treatment of patients with obliterating atherosclerosis of the lower extremity arteries].
January 2006, Vestnik khirurgii imeni I. I. Grekova,
Kh Khaĭne, and K Norden, and Kh Makh, and Kh Shmidt
[Long-term results of the reconstruction of peripheral arteries in obliterating arteriosclerosis].
February 1973, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
Kh Khaĭne, and K Norden, and Kh Makh, and Kh Shmidt
[Efficacy of walking training in patients with obliterating atherosclerosis of lower limb arteries].
January 2017, Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery,
Kh Khaĭne, and K Norden, and Kh Makh, and Kh Shmidt
[Long-term results of dyslipoproteinemia surgical correction in patients with obliterating atherosclerosis of the lower extremity].
January 2010, Vestnik khirurgii imeni I. I. Grekova,
Kh Khaĭne, and K Norden, and Kh Makh, and Kh Shmidt
[Prognosis of ischemic heart disease in patients with obliterating atherosclerosis of lower limb arteries].
January 2000, Klinicheskaia meditsina,
Kh Khaĭne, and K Norden, and Kh Makh, and Kh Shmidt
[Microcirculatory status of patients with obliterating atherosclerosis of the arteries of the lower extremities].
May 1984, Khirurgiia,
Kh Khaĭne, and K Norden, and Kh Makh, and Kh Shmidt
[The use of therapeutic physical factors in obliterating diseases of the peripheral arteries].
January 1991, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
Kh Khaĭne, and K Norden, and Kh Makh, and Kh Shmidt
[The endothelium dysfunction: principles of diagnosis and clinical significance in obliterating atherosclerosis of the peripheral arteries].
January 2005, Vestnik khirurgii imeni I. I. Grekova,
Kh Khaĭne, and K Norden, and Kh Makh, and Kh Shmidt
[A study of the pulse of the peripheral arteries in patients with obliterating endarteritis].
February 1960, Klinicheskaia meditsina,
Kh Khaĭne, and K Norden, and Kh Makh, and Kh Shmidt
[Allergy in patients with obliterating diseases of the peripheral arteries if the lower extremities].
August 1972, Khirurgiia,
Copied contents to your clipboard!